481 results about "Glucosamine" patented technology

The invention provides a composition for improving bone joint health as well as a preparation method and application thereof, and relates to the technical field of bone joint health products. The composition for improving bone joint health is prepared from the following components in parts by mass: 0.5 to 5 parts of collagen peptide, 5 to 30 parts of mangosteen extract, 0.5 to 3 parts of non-denatured II type collagen peptide, 0.1 to 2 parts of milk mineral salt, 0.3 to 3 parts of bone collagen peptide, 0.1 to 2 parts of cartilage extract, 0.1 to 2 parts of N-acetylglucosamine, 0.1 to 2 parts of sodium hyaluronate and 0.3 to 3 parts of turmeric extract. The composition obtained by repeatedly compounding the mangosteen extract, the turmeric extract, the cartilage extract and the sodium hyaluronate has the advantages of low cost and high safety, and has a better effect on preventing or improving osteoarthrosis.

The invention discloses application of a ganoderma lucidum strain SS30 in preparation of a product for treating cancers, and belongs to the technical field of biology. The invention provides ganoderma lucidum strain SS30 mycelium polysaccharide. The ganoderma lucidum strain SS30 mycelium polysaccharide is prepared from glucose, galactose, mannose, fucose, xylose, arabinose, rhamnose, glucuronic acid, glucosamine, ribose and lacturonic acid. The polysaccharide has a remarkable effect of inhibiting transplantable pancreatic cancer and primary colorectal cancer, can achieve the effect of treating cancer by improving the immune function and reducing the oxidation product generation level, provides a new material for development and utilization of lucid ganoderma and products thereof, and has a wide application prospect. And a research basis is provided for research and development of cancer-related drugs and research of a cancer treatment mechanism.

The invention relates to a cartilage organ constructed on the basis of a DNA-silk fibroin hybrid hydrogel sustained-release system as well as a preparation method and application of the cartilage organ. The DNA-silk fibroin hybrid hydrogel sustained-release system is a hydrogel system formed by printing a DNA-silk fibroin hybrid hydrogel sustained-release system premix solution through a digital light processing system, and the DNA-silk fibroin hybrid hydrogel sustained-release system premix solution contains DNA, silk fibroin, acryloylated RGD peptide, acryloylated polyethylene glycol NHS ester, glucosamine, TD-198946 and 2, 4, 6-trimethyl-1, 3-pentanediol. The invention discloses a lithium 2, 6-trimethylbenzoyl phosphate. Compared with the prior art, the glucosamine and the TD-198946 introduced into the DNA-silk fibroin hybrid hydrogel sustained-release system disclosed by the invention can be used for remarkably improving and promoting the cartilage differentiation efficiency of the bone marrow mesenchymal stem cells; the cartilage graft can be transplanted to a cartilage defect position as a cartilage graft to promote cartilage regeneration and repair.

The invention relates to a medicine for repairing skin wounds and a preparation method thereof, and belongs to the technical field of biological medicines.The medicine is prepared from, by mass, 25-30 parts of bee embryo peptide, 8-10 parts of alkannin derivative, 10-15 parts of armillaria mellea polysaccharide, 8-10 parts of inonotus obliquus polysaccharide, 6-8 parts of notoginsenoside and 5-7 parts of astragaloside. The bee fetus peptide is a product which is more than 500Da and is obtained by performing step-by-step enzymolysis on bee larva freeze-dried powder through trypsin and bacillus subtilis neutral protease to obtain enzymatic hydrolysate which is less than 3kDa, performing purification through a G-50 sephadex column, performing ultrafiltration and performing freeze-drying. The alkannin derivative is obtained by reacting alkannin with succinic anhydride and glucosamine-polyethylene glycol. A special method is adopted for preparing the bee embryo peptide and alkannin derivatives, the bee embryo peptide and alkannin derivatives are matched with other components to play a synergistic role, and the effects of high safety, high skin cell proliferation promoting capacity, excellent antibacterial performance and the like are achieved.

The invention provides an engineering bacterium for producing 3 '-sialyllactose as well as a construction method and application thereof. The engineering bacterium has the capability of generating 3 '-sialic acid lactose, and an exogenous UDP-N-acetyl glucosamine-2-epimerase gene (neuC), a sialic acid synthase gene (neuB), an N-acetylneuraminic acid cytidyltransferase gene (css) and an alpha-2, 3-sialic acid transferase gene (ST) are introduced into a genome of the engineering bacterium or a recombinant plasmid carried by the engineering bacterium. The engineering bacterium has high capacity of producing 3 '-sialyllactose under the condition that antibiotics are not needed.

The invention relates to the technical field of synthetic biology, metabolic engineering and cell culture. The present invention provides a cell for the production of a negatively charged, preferably sialylated, oligosaccharide wherein the cell is genetically engineered to have or express, preferably overexpress, a hydrolytic UDP-N-acetyl-D-glucosamine-2-epimerase. The invention further provides the use of said cells in culture or incubation. Also described are methods of producing negatively charged, preferably sialylated oligosaccharides using the cells, and purification of the negatively charged, preferably sialylated oligosaccharides.

The present invention relates to a recombinant yeast cell that produces UDP-D-glucuronic acid and / or UDP-N-acetyl-D-glucosamine compared to a wild type cell of the recombinant yeast cell; and optionally, the yield of 3 '-phosphate-adenylate sulfuric acid is increased. The invention also relates to a method for producing heparan sulfate, which comprises a step of culturing the recombinant yeast cell, further relates to an application of the non-invasive recombinant yeast cell for producing heparan sulfate, and finally relates to heparan sulfate obtained by applying the method.

The invention belongs to the technical field of gene engineering, and particularly relates to an LgtA mutant and application thereof in production of human milk oligosaccharide. According to the present invention, a gene editing technology is adopted to mutate a key enzyme beta-1, 3-N-acetyl glucosamine transferase for synthesizing an intermediate product LNT II so as to obtain a mutant having at least one of R13H mutation, L24M mutation and R205C mutation on the basis of a wild type LgtA represented by SEQ ID NO.1; further, the mutant is applied to the construction process of production plasmids of the LNTII, the LNnT and the LNT, and the yield of the LNTII, the LNnT and the LNT is further increased.

The invention belongs to the field of preparation of soil conditioners, and particularly relates to a soil loosening and root promoting soil conditioner and a preparation method thereof. A polymer formed by vinyltriethoxysilane, polyacrylic acid and coumarin under the catalytic action of citric acid is mixed with porous powder obtained after crushing and nutrient organic matter, and freeze-drying is performed to obtain the soil-loosening improved fermentation substrate which can be slowly released in soil; polyaspartic acid and acetylchitosamine are cross-linked under the catalytic action of N-hydroxysuccinimide, root-promoting nutrition powder and auxiliary root-promoting components are mixed, and the obtained composite root-promoting agent can significantly promote the growth of plant root systems; a porous structure contained in the protective stability maintaining agent can provide a relatively stable microenvironment for effective components, and the soil loosening and root promoting agent is mixed with the soil loosening and improving fermentation substrate and the composite root promoting agent, so that the prepared soil loosening and root promoting soil conditioner is remarkable in soil loosening and root promoting effect, long-acting and stable, small in dosage, obvious in effect and stable in conditioning effect after being stored.

The invention discloses an engineering bacterium for producing D-glucosamine by a fermentation method and application of the engineering bacterium. The engineering bacteria comprise modification (a) and modification (e) for escherichia coli; the transformation (a) comprises the following transformation: knocking out a pfkA gene, knocking out a pfkB gene, knocking out a zwf gene, knocking out manXYZ, knocking out a nagE gene, knocking out a nagB gene, enhancing the expression of an araE gene, replacing a ptsG gene with a glk gene, and replacing a galR gene with a Zglf gene; the modification (e) comprises the following modification: introducing and expressing an EcGlmS gene and a BtGlmP gene. The engineering bacteria prepared by the invention can grow and accumulate biomass by using glycerol or grease as a carbon source, and meanwhile, D-glucose is further converted and synthesized into D-glucosamine by using the accumulated biomass. The engineering bacterium disclosed by the invention has a good application prospect in industrial production of D-glucosamine.

The invention discloses a ferroptosis inhibitor and application of the ferroptosis inhibitor in radiation pneumonitis drugs, and relates to the technical field of biological medicines. The specific preparation method comprises the following steps: adding the ferroptosis inhibitor and the auxiliary agent into the solvent, and dissolving to obtain the ferroptosis inhibitor composition; wherein the ferroptosis inhibitor is isoorientin; the auxiliary agent is a glucosamine derivative; the solvent is a serum-free DMEM culture medium. The ferroptosis inhibitor composition prepared by the method provided by the invention can effectively reduce the rise of active oxygen, ferrous ions and malondialdehyde levels of human pulmonary epithelial cells BEAS-2b and mouse pulmonary epithelial cells MLE-12 caused by irradiation, restore cell mitochondrial membrane potential enrichment and inhibit the expression of various inflammatory factors in irradiated cells; therefore, the process of radiation pneumonitis is remarkably improved, and a new medication strategy is provided for research on radiation pneumonitis drugs.

A nutraceutical composition, consisting of Nicotinamide Mononucleotide in a range 250-1000 mg, Spermidine in a range 0.5-10 mg, Rhodiola Rosea in a range 200-600 mg, Cacao in a range 1000-10,000 mg, L-Theanine in a range 50-200 mg, Glucosamine in a range 500-3000 mg, and Hyaluronic acid in a range 50-240 mg, or consisting of Epigallocatechin-3-gallate in a range 100-500 mg, Quercetin in a range 250-1000 mg, Resveratrol in a range 150-1000 mg, Sulforaphane in a range 1-50 mg, and Calcium Alphaketoglutarate in a range 300-2000 mg, or consisting of Microdose Lithium in a range 1-5 mg, Trimethylglycine in a range 500-2000 mg, Glutathione in a range 250-1000 mg, Fisetin in a range 100-1000 mg, Urolithin A in a range 250-2000 mg, Sodium Butyrate in a range 100-3000 mg, Berberine in a range 500-1500 mg, Apigenin in a range 50-500 mg, Cinnamon in a range 1000-6000 mg, and Malate in a range 1000-6000 mg.

The invention discloses an oral joint protection composition containing ergothioneine and a preparation method thereof, and relates to the technical field of joint protection compositions. The oral joint protection composition containing the ergothioneine is prepared from the following components in parts by mass: 0.05 to 5 parts of the ergothioneine, 20 to 50 parts of glucosamine salt, 10 to 30 parts of chondroitin sulfate, 2 to 10 parts of curcumin, 30 to 70 parts of a diluent, 1 to 10 parts of an adhesive, 0.5 to 5 parts of a lubricant, 2 to 10 parts of a disintegrating agent and 0.1 to 0.5 part of an antioxidant stabilizer. Through synergistic compatibility of active ingredients such as ergothioneine, curcumin and the like, a multi-dimensional action network of oxidation resistance, inflammation resistance and cartilage metabolism regulation is formed, the inhibition effect on joint inflammation is remarkably improved, and the limitation of a single ingredient is broken through.

The disclosure relates, in part, to the use of compositions of poly N-acetylated glucosamine (PNAG), deacetylated PNAG (dPNAG), and antibodies and antibody fragments specific to PNAG in the prevention and treatment of filariasis.

The utility model discloses a stirring device for processing glucosamine products, which comprises a main body unit comprising a stirring drum, and the upper end face of the stirring drum is fixedly connected with a feeding drum. A connecting cover is taken down, various raw materials of glucosamine are added into a stirring barrel from a feeding barrel, a servo motor is started, the output end of the servo motor drives a connecting rod to rotate, the connecting rod drives a connecting column block to rotate, then a first stirring rod and a second stirring rod are driven to rotate, and the connecting rod drives a first rotating rod to rotate; the first rotating rod drives a first gear, the first gear drives a second rotating rod to rotate through a second gear, then a first stirring rod and a second stirring rod are driven to rotate around the first rotating rod and the second rotating rod correspondingly, and the rotating directions of the first stirring rod and the second stirring rod are opposite. Therefore, the first stirring rod and the second rotating rod can uniformly stir various raw materials of the glucosamine, and the stirring effect of the various raw materials of the glucosamine is improved.

The invention discloses a composition with sensitive skin repairing and anti-aging functions as well as an emulsion and application of the composition, and belongs to the technical field of cosmetics. The composition specifically comprises a pseudoalteromonas fermentation product extract, collagen, palmitoyl tripeptide-5, acetylchitosamine, sodium hyaluronate, silanetriol, caffeine and acetyl hexapeptide-8, and can promote the generation of laminin-5 and integrin beta1, promote the vitality of keratinocytes and fibroblasts, inhibit the growth of the keratinocytes and the fibroblasts, inhibit the growth of the keratinocytes and the fibroblasts, inhibit the growth of the keratinocytes and the fibroblasts, and promote the growth of the keratinocytes and the fibroblasts. The generation of inflammatory factors (IL-6) is inhibited; the generation of collagen IV and collagen VII is promoted; the invention further provides an emulsion prepared from the composition, and the optimal formula of the emulsion is obtained through optimization. The active composition disclosed by the invention has a wide application prospect in the field of cosmetics, and particularly has important significance in sensitive skin repair and anti-aging directions.

The invention relates to a pharmaceutical composition for treating pancreatic cancer, and belongs to the technical field of biological medicines. The mass ratio of the resveratrol to the glucosamine is (2.28 mg-45.6 mg): (179.17 mg-895.85 mg), and the pharmaceutical composition group is applied to preparation of products for treating pancreatic cancer or preventing pancreatic cancer metastasis. Compared with a single medication group, the combined application of the resveratrol and the glucosamine has the advantages that the metastasis and invasion capability of pancreatic cancer cells can be more obviously inhibited, and the influence on normal cells is smaller. Researches show that the resveratrol realizes an anti-tumor effect by inhibiting the expression of a ligand in a TGF-beta (Transforming Growth Factor-beta) pathway; and the glucosamine inhibits N-glycosylation modification and further inhibits the stability of a receptor in a TGF-beta pathway so as to realize an anti-tumor effect. And a synergistic interaction effect is achieved through multiple targets on the same path. Therefore, the method has good practical application value.

The invention relates to a method for producing 6 '-fucosylated chitosan disaccharide GlcNacbeta1-4 (Fucalpha1-6) GlcNAc through double-bacterium coupling fermentation, and belongs to the technical field of fermentation engineering. The method comprises the following steps: taking fucose and N-acetyl-D-glucosamine as substrates in a fermentation system; the 6 '-fucosylated chitosan disaccharide is produced through coupled fermentation of an engineering escherichia coli strain and yeast, and a GlcNAcbeta1-4 (Fucalpha1-6) GlcNAc synthesis pathway including N-acetylhexosamine 1-kinase nahK, fucosyltransferase nodZ, L-fucose kinase Fkp and N, N-diacetylchitosan phosphorylase Chbp is constructed in the engineering escherichia coli, so that the 6'-fucosylated chitosan disaccharide is obtained. According to the invention, the yeast is added to realize cyclic regeneration from GMP to GTP, so that not only is the problem of high oligosaccharide production cost caused by pure exogenous supplement of GTP effectively solved, but also efficient production of GlcNAcbeta1-4 (Fucalpha1-6) GlcNAc is realized, and the yield of GlcNAcbeta1-4 (Fucalpha1-6) GlcNAc is increased to 25.50 g / L by an optimized coupling fermentation production technology. The invention provides a novel synthesis technology of complex N-glycans, and has a wide application prospect.

The invention relates to an N-acetyl-D-glucosamine composition with an anti-tumor effect and application of the N-acetyl-D-glucosamine composition, and relates to the technical field of medicines and health care products, the N-acetyl-D-glucosamine composition with the anti-tumor effect comprises the following raw materials by weight: 17-29 parts of N-acetyl-D-glucosamine and 5-10 parts of an extract of Tongshan. According to the invention, the N-acetyl-D-glucosamine and the extract in a proper proportion are matched for use for the first time, so that the synergistic interaction of the N-acetyl-D-glucosamine and the extract is realized. In-vitro animal anti-tumor experiments show that the N-acetyl-D-glucosamine composition provided by the invention can significantly reduce the tumor volume in a rat model, provides a new way for clinical treatment of tumor patients, and has a wide application prospect.

The invention belongs to the technical field of genetic engineering, and discloses a safe recombinant bacillus subtilis for synthesizing lactoyl-N-neotetraose and a construction method and application thereof, and the recombinant bacillus subtilis is obtained by converting a recombinant bacillus subtilis containing beta-1, 3-N-acetyl glucosamino transferase, beta-1, 3-N-acetyl glucosamino transferase, beta-1, 3-N-acetyl glucosamino transferase and beta-1, 3-N-acetyl glucosamino transferase in bacillus subtilis 168. The recombinant plasmid is obtained by plasmids of a 1, 4-galactosyl transferase gene and a lactose permease gene. The invention provides an engineering bacterium for producing lactyl-N-neotetraose and an application of the engineering bacterium to meet the demand of the market on lactyl-N-neotetraose aiming at the huge demand of the market on lactyl-N-neotetraose and insecurity of lactyl-N-neotetraose produced by most of the existing engineering bacteria in the prior art.

The application relates to a cartilage organoid based on a DNA-silk fibroin hybrid hydrogel sustained-release system and a preparation method and application thereof. The DNA-silk fibroin hybrid hydrogel sustained-release system is a hydrogel system after a DNA-silk fibroin hybrid hydrogel sustained-release system premixing solution is printed through a digital light processing system, wherein the DNA-silk fibroin hybrid hydrogel sustained-release system premixing solution contains DNA, silk fibroin, acrylated RGD peptide, acrylated polyethylene glycol NHS ester, glucosamine, TD-198946 and 2,4,6-trimethylbenzoyl lithium phosphate. Compared with the prior art, the glucosamine and TD-198946 introduced in the DNA-silk fibroin hybrid hydrogel sustained-release system can significantly improve the cartilage differentiation efficiency of bone marrow mesenchymal stem cells; and the application can be transplanted to a cartilage defect as a cartilage graft to promote cartilage regeneration and repair.

The present invention relates to a highly soluble composition containing cosmetic actives, its preparation and application, belonging to the technical field of cosmetics. The highly soluble composition containing cosmetic actives of the present invention comprises cosmetic actives and a solvent; the cosmetic actives are selected from one or more of glycyrrhetinic acid, asiatic acid and madecassic acid; the solvent comprises hexylene glycol, methyl glucamine and water. Methyl glucamine has multiple hydroxyl groups in its structure and has good water solubility. By combining the amino group in its structure with the carboxyl group on the cosmetic actives, the hydrophilicity of the cosmetic actives is increased. Hexylene glycol has the characteristics of being amphiphilic for oil and water and can play a bridging role in dissolving the cosmetic actives, promoting the combination of the cosmetic actives and methyl glucamine, thus playing a synergistic effect. At the same time, the amount of solvent used can be greatly reduced, and the dissolution efficiency of the cosmetic actives can be greatly improved, thereby realizing the application value in cosmetics.

The invention discloses a fluorescent probe aiming at D-glucosamine as well as a preparation method and a detection method thereof. The specific chemical structural formula of the fluorescent probe is as follows: # imgabs0 # fluorescent probe has the advantages of simplicity in preparation, high detection sensitivity and good selectivity.

The invention relates to the technical field of medicinal chemistry, and provides a TLR4 agonist, application thereof and a vaccine composition. The TLR4 agonist is a compound with a structure as shown in a formula 1 or a pharmaceutically acceptable salt thereof, the compound is glucosamine aminoalkyl 4-phosphate series molecules derived from MPL-12 structure modification, and the series molecules have enhanced immunostimulatory activity and selective immune response induction capability.

The invention relates to the field of detection, in particular to a method for detecting glucosamine in food, which comprises the following steps: firstly, judging whether an interfering substance capable of reacting with glucosamine exists in a sample solution or not, if so, adjusting the centrifugal rotating speed in a targeted manner, and if not, judging whether the interfering substance reacts with the glucosamine; the temperature of the position where the glucosamine is located in the centrifugation process does not exceed the temperature required by any reaction, so that the glucosamine is prevented from being converted into other substances due to the reaction in the centrifugation process, and the accuracy of the content of the glucosamine detected by the solution can be ensured.

The present invention discloses a fluorescent probe, comprising a carbon dot surface functionalised with glucosamine. The present invention also provides a method of fabricating a fluorescent probe and a method of staining a nucleolus of a cell by contacting the fluorescent probe as disclosed herein with the cell.

The invention relates to a gastric acid-resistant sustained-release intestinal bacteria capsule based on bionic mucous membrane-enzymolysis response and a preparation method thereof. The gastric acid-resistant sustained-release intestinal bacteria capsule comprises a core layer, an adhesive layer, an outer-layer composite film and a protective coating from inside to outside, the core layer consists of intestinal flora and a multifunctional freeze-drying protective agent; the adhesive layer is composed of trehalose, N-acetyl glucosamine and MUC2 recombinant protein; the outer-layer composite film is composed of a base material and a functional filler; the protective coating is composed of beewax and chitosan. The anti-gastric acid sustained-release intestinal bacteria capsule based on bionic mucosa-enzymolysis response provided by the invention has excellent gastric acid resistance, and the gastric acid resistance is remarkably improved; good slow release performance is achieved, and accurate slow release of enzymatic hydrolysis response can be achieved; the colonization efficiency of the intestinal bacteria can be effectively improved; the storage stability is good. The preparation method provided by the invention has the advantages of simplified steps, short time consumption, controllable core operation time and obviously shortened whole process, and is beneficial to keeping the activity of the flora.

The invention provides a collagen-containing composition which comprises the following components in parts by weight: 15-30 parts of a collagen mixture, 10-20 parts of a plant extract, 2-4 parts of a vitamin mixture, 1-3 parts of D ribose and 3-7 parts of glucosamine, the collagen mixture is fish scale collagen, deer collagen and bovine bone collagen; the plant extract is an ethanol extract obtained by mixing rhizoma phragmitis, cherries, grapes, liriodendron tulipifera, blueberries, caulis sinomenii and sagittaria sagittifolia; the vitamin mixture is a mixture of vitamin B, vitamin C and vitamin E; when the composition is applied to food, the effects of obviously improving skin and resisting aging can be achieved.

The invention discloses an NMN and bisabolol supramolecule as well as a preparation method and application of the NMN and bisabolol supramolecule. The method comprises the following steps: mixing NMN, choline chloride and glucosamine to form a transparent homogeneous liquid under the protection of nitrogen; and adding (-) alpha-bisabolol into the transparent homogeneous liquid, stirring and mixing, and carrying out vacuum degassing treatment to obtain the NMN and (-) alpha-bisabolol supramolecules. The obtained supramolecule solves the problem that the NMN and the (-) alpha-bisabolol are immiscible with each other, and meanwhile, the permeation resistance is reduced, and the transdermal absorption is promoted, so that the NMN and the (-) alpha-bisabolol cooperate with the skin to resist light aging. The invention further provides a method for preparing the supramolecules into the lipidosome through a lipidosome wrapping technology, the supramolecules achieve supramolecular smearing type skin care by means of the lipidosome wrapping technology, operation is easy and convenient, and the effect is fast. The method is suitable for preparing the skin anti-photoaging preparation.

The invention discloses a water quality conditioning agent based on plant extracts and a preparation method of the water quality conditioning agent, and belongs to the technical field of aquaculture. The water quality conditioning agent is prepared from the following raw materials in parts by weight: 14 to 18 parts of fructus schisandrae chinensis extract, 4 to 5 parts of fructus mume extract, 10 to 13 parts of rhizoma coptidis extract, 8 to 10 parts of glucosamine, 5 to 8 parts of chitosan, 3 to 6 parts of nitrifying bacteria, 2 to 4 parts of thiobacillus thiooxidans and 3 to 6 parts of zeolite powder. Through a four-dimensional synergistic mechanism of'plant active ingredient-chitosan slow release-microbial immobilization-zeolite adsorption ', the pH value, ammonia nitrogen, nitrite, hydrogen sulfide and bottom mud COD in tail water can be reduced and the dissolved oxygen amount can be increased under the condition of one-time addition, which indicates that the water quality regulator has a good effect of improving water quality.